KS
Kuldeep Sangwan
About Kuldeep Sangwan
Data last updated:
Kuldeep Sangwan is a Director at Dansk Pharmaceuticals India Private Limited (since 2020). The company operates in Pharma. Dansk Pharmaceuticals India Private Limited reported revenue of ₹2.43 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Dansk Pharmaceuticals India Private Limited U24230HR2020PTC086501 | Director | 02 Jun 2020 | 2020 | ₹2.43 Cr (FY 2024) | Active |
Board colleagues of Kuldeep Sangwan
| Name | DIN | Company | Designation |
|---|---|---|---|
| Bhagat Singh | 01183651 | Dansk Pharmaceuticals India Private Limited | Director |
| Harinder Singh | 09047224 | Dansk Pharmaceuticals India Private Limited | Director |
| Ravipal Singh Rulania | 03189246 | Dansk Pharmaceuticals India Private Limited | Director |
| Sunil Kumar | 08751742 | Dansk Pharmaceuticals India Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kuldeep Sangwan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kuldeep Sangwan
Kuldeep Sangwan currently holds 1 directorship: Dansk Pharmaceuticals India Private Limited (Director, since 02 Jun 2020, revenue ₹2.43 Cr (FY 2024)).
Kuldeep Sangwan was first appointed on 02 Jun 2020 as Director at Dansk Pharmaceuticals India Private Limited.
The current boards of Kuldeep Sangwan's companies include Bhagat Singh (Dansk Pharmaceuticals India Private Limited), Harinder Singh (Dansk Pharmaceuticals India Private Limited), Ravipal Singh Rulania (Dansk Pharmaceuticals India Private Limited), Sunil Kumar (Dansk Pharmaceuticals India Private Limited).